$EXPD

Expeditors International's Quarterly Earnings Preview: What You Need to Know

Expeditors International (EXPD) is set to report Q2 2026 earnings on Aug. 4 before the open. Analysts expect diluted EPS of $1.64, up from $1.34 a year earlier. For fiscal 2026, EPS is projected at $6.71. The stock has risen 60.5% over 52 weeks; its average price target is $162.

Original reporting
Published Jul 21, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Expeditors International's Quarterly Earnings Preview: What You Need to Know — source image
Decision brief

The 30-second read

$EXPDNeutralLow
01

Why it matters

Traders can use the consensus EPS ($1.64) and the stated history of beating estimates to calibrate expectations, but there is no new guidance, filing, or event disclosed in the text.

02

Market read

This is primarily an earnings calendar and consensus snapshot, useful for planning around volatility rather than for a new fundamental re-rate.

03

What to watch

The preview omits key items traders often anchor on, such as management guidance, segment margins, and any freight-rate or volume inflection.

Relevance 4/10Novelty 3/10Timing: Ahead of Q2 2026 earnings on Tuesday, Aug. 4 before the open.

Background

Expeditors International (EXPD) is a logistics provider; the article frames expectations for its upcoming Q2 2026 earnings release.

Company-level read

Ticker impact

$EXPDNeutralMedium confidence
Context

Expeditors International is set to report Q2 2026 earnings Aug. 4, with consensus EPS $1.64 and prior four-quarter estimate beats.

Expected impact

Likely elevated volatility into Aug. 4; direction depends on whether results and guidance beat or miss the $1.64 EPS consensus.

Evidence & confidence

Previews typically inform positioning, but the text does not include a fresh print, guidance change, or analyst action that would be a new catalyst today.

Market effects

Provides a read-through for logistics/transportation earnings expectations, but lacks sector-wide new data.

Limited, as the piece is company-specific and does not introduce regional demand indicators.

Low, since it does not cite new global trade, freight rates, or macro shocks.

Counterpoint

A consensus beat is not guaranteed; freight/logistics earnings can swing on margins and guidance even when EPS expectations are met.

Key entities

  • Expeditors International of Washington, Inc.

    Subject of the earnings preview, expected to report Q2 2026 earnings Aug. 4 before the market opens.

Related articles

$EXPDMedAI 8/10

Expedition raises $115m Series B to advance COPD drug

Expedition raised $115m in a Series B to advance its COPD drug EXPD-101 through an ongoing Phase II trial (NCT07684820), and to expand its pipeline and discovery platform, according to CEO Yi Larson. EXPD-101 targets neutrophilic inflammation via DPP1 inhibition. The company cited prior Phase I results showing tolerability and once-daily oral dosing support.

$EXPDHigh

EXPEDITORS INTERNATIONAL OF WASHINGTON INC (EXPD): Results of Operations and Financial Condition

EXPEDITORS INTERNATIONAL OF WASHINGTON INC (EXPD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 expd-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 EARNINGS RELEASE By: Expeditors International of Washington, Inc. 3545 Factoria Blvd. SE Sterling Plaza 2, 3rd Floor Bellevue, Washington 98006 CONTACTS : Daniel R. Wall David A. Hackett Geoffrey Buscher President and Chief E

$EXPDMedAI 8/10

Strong quarter for Expeditors, air freight leads the way

Expeditors International reported Q2 results with airfreight volume up 14% year over year (13% April, 14% May, 15% June). Ocean freight was mixed, flat overall. Revenue rose 32% to $3.5B, operating income up 41% to $349.6M, and net income to $2.03 per share. CEO Daniel Wall cited strong air demand and tariff-driven customs activity.

$EXPDMed

Expeditors International Of Washington Q2 Earnings Rise

Expeditors International of Washington (EXPD) reported Q2 earnings of $266.2 million, or $2.03 per share, up from $183.6 million, or $1.34 per share, a year earlier. Revenue increased 32% to $3.502 billion from $2.651 billion. The company said results reflected double-digit growth across most products. EXPD last traded at $171.89 on the NYSE.

$EXPDMedAI 8/10

Expeditors’s (NYSE:EXPD) Q2 CY2026: Strong Sales

Expeditors (NYSE:EXPD) reported Q2 CY2026 revenue of $3.50 billion, up 32.1% year on year and 18.6% above Wall Street estimates, and GAAP EPS of $2.03, 19.9% above consensus. The board declared a semi-annual dividend of $0.81 per share payable June 15, 2026. Analysts expect revenue growth of 1.1% over the next 12 months.

$ACHRMed

Anduril and Archer's autonomous VTOL platform, Expeditors' AOG expansion, and StandardAero's Arajet deal headline a busy day in aviation logistics

On July 20, 2026, Anduril and Archer Aviation (NYSE: ACHR) unveiled at Farnborough a dual-use autonomous VTOL platform, with a defense variant called Thunder, per Business Wire. Expeditors International (NYSE: EXPD) expanded its Aircraft on Ground coverage. StandardAero (NYSE: SARO) signed an LEAP-1B MRO deal with Arajet. Loganair signed a term sheet to buy BETA Technologies (NYSE: BETA) electric ALIA aircraft.